Ab1042 #ACR22 Ixekizumab Long-term Safety
A Deodhar: Pooled 25 studies for PsO, PsA, AS
5.4 pooled AE per 100-patient/year
0.5 IBD per 100-PY
1.3 Oral candidiasis per 100-PY
Re-assuring safety numbers. Deodhar: "These are numbers to use in clinical practice"
@RheumNow
Links:
13-11-2022


